Washington: New research suggests that treatment with the cholesterol drug simvastatin significantly reduces lung damage resulting from severe abdominal sepsis and infection."We hope that this study will not only provide new knowledge about the complicated pathophysiology behind abdominal sepsis, but also form the basis for more effective and specific treatment options for patients with severe infections," said Henrik Thorlacius, a researcher involved in the workfrom the Department of Surgery at Skane University Hospital at Lund University, Malmo, Sweden.
The study was recently published in the Journal of Leukocyte Biology. ANI
Curfew relaxed for 4 hours in Saharanpur
Refund fares for flight delay: DGCA to Spicejet
Farmers should get better technology: PM
Delhi shame: Class 10th student gang-raped in Uttam Nagar at gun point